Brief: Xbrane Biopharma Announces Results Of In-Vivo Study Showing Equivalent Tolerability And Pharmacokinetic Profile Of Xlucane Compared To Lucentis
04/10/2018 07:06
Oct 4 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* REG-XBRANE BIOPHARMA ANNOUNCES RESULTS OF IN-VIVO STUDY
SHOWING
EQUIVALENT TOLERABILITY AND PHARMACOKINETIC PROFILE OF XLUCANE
COMPARED TO LUCENTIS®
* "WE ARE VERY PLEASED WITH RESULT OF THIS STUDY"
Source text for Eikon: ID:nGNE8P9L93
Further company coverage: XBRANE.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))